The role of matrilysin (MMP-7) in leukaemia cell invasion

Clinical and Experimental Metastasis

Volumn 18, Issue 5, 2000, Pages 401-406

  Lynch, Conor C ^a   McDonnell, Susan ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Invasion; Leukaemia; Matrilysin; Matrix metalloproteinase; Tissue inhibitors of metalloproteinases

Indexed keywords

MATRILYSIN; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL CULTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOGENICITY TESTS; CRICETINAE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED;

EID: 0034957032     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010973808853     Document Type: Article

References (26)

1. Leukemia and the disruption of normal haematopoiesis
2. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes
3. Role of matrix metalloproteinases in normal and disease processes
4. Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis
6. Matrix metalloproteinases: Biologic activity and clinical implications
7. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis
8. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
9. Matrilysin in early stage intestinal tumorigenesis
10. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
11. Tissue inhibitors of metalloproteinases: Evolution, structure and function
12. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells
13. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: Comparison with normal bone marrow cells
14. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas
15. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
16. Plasminogen activation on tumor cell surface and its involvement in human leukemia
17. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells
18. Increased incidence of matrix metalloproteinases in urine of cancer patients
19. Modulation of matrilysin levels in colon-carcinoma cell-lines affects tumorigenicity in vivo
20. Inhibtion of collagenolytic activity and metastases of tumor cells by a recombinant human tissue inhibitor of metalloproteinases
21. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
22. Matrix metalloproteinases and their inhibitors in tumour growth and invasion
23. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differectiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity
24. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells
25. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin
26. Proteolysis and cell migration: Creating a path?